We know the molecules
Genomics, transcriptomics, and proteomics have transformed target identification. But a neuron is defined by what it does — not just what it expresses.
Neural Discovery Platform
The problem with CNS drug discovery isn't the science, it's the data
We're building a platform to help drug developers understand what neurons actually do, turning functional neural phenotypes into better translational decisions.
We don't know the function
How do neurons fire? How do networks synchronise? How does a drug change those patterns? These questions are currently answered slowly, expensively, and incompletely.
The result: missed opportunities and trial failures
Our technology generates AI ready data that will transform CNS discovery by bridging the gap from molecules to functional outcomes.
The Calypte Platform turns neural activity into discovery-ready evidence
We'll only use this to get in touch.